Nome Bio

San Diego, United States

Nome is the Operating System for Personalized Therapies™ — developing custom treatments for rare disease patients, families, and clinicians.

$2.7M raised

Oct 2025

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Nome Bio raised?

Nome Bio has raised $2.7M in total funding. The most recent round was Seed. The last funding was announced in October 2025.

Who are Nome Bio's investors?

Nome Bio's investors include Twelve Below, Refactor, Inflect Health.

Where is Nome Bio headquartered?

Nome Bio is headquartered in San Diego, United States.

What does Nome Bio do?

Nome is the Operating System for Personalized Therapies™ — developing custom treatments for rare disease patients, families, and clinicians.

What stage is Nome Bio at?

Nome Bio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 15, 2025.

MLA

"Nome Bio — Funding & Investors." VCBacked, October 15, 2025, https://www.vcbacked.co/company/nome-bio. Accessed July 2, 2026.

APA

VCBacked. (2025). Nome Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/nome-bio

Wikipedia (cite web)

{{cite web |title=Nome Bio — Funding & Investors |url=https://www.vcbacked.co/company/nome-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 15, 2025.